XML 61 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share Options (Tables)
 12 Months Ended
Dec. 31, 2023
Share Options [Abstract]  
Schedule of Company’s Share Option Activity for Employees and Members of the Board of Directors The following table presents the Company’s share option activity for employees and members of the Board of Directors of the Company under the Plan for the years ended December 31, 2023, 2022 and 2021:
   Number of
Share		  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual		   Intrinsic
value		 
   Options   $   life (years)   $ 
                 
Outstanding as of December 31, 2020   1,254,000    1.70    6.12    125 
Granted   214,688    2.05    9.64      
Forfeited or expired   (101,520)   1.80    
-
      
Outstanding as of December 31, 2021   1,367,168    1.75    5.72    4,860 
Exercisable as of December 31, 2021   927,988    1.60    4.25    3,429 
   Number of
Share		  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual		   Intrinsic
value		 
   Options   $   life (years)   $ 
                 
Outstanding as of December 31, 2021   1,367,168    1.75    5.72    4,860 
Granted   286,875    1.83    
-
    
-
 
Forfeited or expired   (83,052)   1.45    
-
    
-
 
Outstanding as of December 31, 2022   1,570,991    1.78    4.97    2,435 
Exercisable as of December 31, 2022   1,048,297    1.70    3.2    1,677 
   Number of
Share		  

Weighted
Average
Exercise
Price

   Weighted
average
remaining
contractual		   Intrinsic
value		 
   Options   $   life (years)   $ 
                 
Outstanding as of December 31, 2022   1,570,991    1.78    4.97    2,435 
Granted   151,600    2.88    
-
    
-
 
Exercised   (168,447)   0.29    
-
    
-
 
Forfeited or expired   (258,777)   1.81    
-
    
-
 
Outstanding as of December 31, 2023   1,295,367    2.09    6.04    84 
Exercisable as of December 31, 2023   863,616    2.07    4.70    84 

 
Schedule of Outstanding and Exercisable Share Options Separated Ranges of Exercise Prices The outstanding and exercisable share options as of December 31, 2023 have been separated into ranges of exercise prices, as follows:

 

Exercise price

  Share options
outstanding
as of
December 31,
2023		   Weighted
average
remaining
contractual
term (years)		   Share options
exercisable
as of
December 31,
2023		   Weighted
average
remaining
contractual
term (years)		 
                 
0.00   22,005    3.61    22,005    3.61 
1.14   166,080    3.01    166,080    3.01 
1.48   50,000    9.70    
-
    
-
 
1.67   43,200    1.21    43,200    1.21 
1.74   12,800    9.30    1,600    9.30 
1.83   765,079    6.96    468,858    6.02 
2.79   6,400    9.59    
-
      
3.2   25,002    7.65    14,064    7.65 
3.79   60,000    0.59    60,000    0.59 
4.00   76,000    9.18    19,008    9.18 
4.17   28,800    2.03    28,800    2.03 
5.12   40,000    5.54    40,000    5.54 
    1,295,367         863,616      
Schedule of Assumptions Used to Estimate the Fair Values of the Share Options Granted The following table presents the assumptions used to estimate the fair values of the share options granted in the reported periods presented:
  

Year ended

December 31

 
   2023   2022   2021 
             
Volatility (%)   60.48%-61.49%   61.49%   64.75%
Risk-free interest rate (%)   3.7%-4.3%   3.64%-3.85%   0.09%
Dividend yield (%)   
-
    
-
    
-
 
Expected life (years)   6.25    6.25    6.25 
Exercise price ($)   1.48-4.00    1.83    1.80-3.20 
Share price ($)   1.48-3.73    3.30    3.20 
Schedule of Company’s Equity-Based Awards Recognized The total compensation cost related to all of the Company’s equity-based awards recognized during the years ended December 31, 2023, 2022 and 2021 was comprised as follows:
  

Year ended

December 31

 
   2023   2022   2021 
             
Research and development  $216   $144   $94 
Sales and marketing   41    49    45 
General and administrative   106    29    18 
   $363   $222   $157